Combating MRSA; combining and increasing our understanding on colonisation, transmission and reservoirs will lead to control of infections by MRSA
Combating MRSA; combining and increasing our understanding on colonisation, transmission and reservoirs will lead to control of infections by MRSA
批准号:
MR/P028322/1
负责人:
Jodi Lindsay
金额:
$51.82万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The underlying reasons for the epidemiological dynamics of MRSA clones in the hospital and the community are debated intensely and different explanations can be controversial. Most studies focus either on the genetic basis of the ability of MRSA to spread and be sustained, like the presence of PVL, SCCmec type IV etc. or on the epidemiological features, like risk groups, selection due to antibiotic use, or prevention measures in health care centres. After introduction of new strains, antibiotic or disinfectant use is an important driving force, prevention should be focused on that point. When selected strains are more able to spread due to their genetic profile, measures should be developed targeted on prevention of transmission of these particular strains. However, a combination of driving forces will be often present. In short, this study will create more insight into the success and failure of MRSA, and together with the mathematical model, will target specific and realistic tools to prevent further spreading and thus disease. This accounts both for hospitalized patients and in otherwise healthy individuals, as present in the large uncontrolled epidemic by USA300. MACOTRA will join approaches on understanding the epidemiology of MRSA together, will add the host-factor and herewith aims to explain the epidemiological behaviour of MRSA in its rise, maintenance or disappearance. We believe that only by combining all these aspects, we can understand the epidemiology and thus design optimal and focused prevention measures.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1128/msystems.00974-22
发表时间:
2023-02-23
期刊:
mSystems
影响因子:
6.4
作者:
[]
通讯作者:
The dual nature of bacteriophage: growth-dependent predation and generalised transduction of antimicrobial resistance
噬菌体的双重性质:生长依赖性捕食和抗菌素耐药性的普遍转导
DOI:
10.1101/2021.07.24.453184
发表时间:
2021
期刊:
影响因子:
--
作者:
[Leclerc Q]
通讯作者:
Leclerc Q
DOI:
10.1128/msystems.00135-22
发表时间:
2022-04-26
期刊:
mSystems
影响因子:
6.4
作者:
[]
通讯作者:
DOI:
10.1128/spectrum.00615-22
发表时间:
2022-10-26
期刊:
MICROBIOLOGY SPECTRUM
影响因子:
3.7
作者:
[Baede, Valerie O., Tavakol, Mehri, Vos, Margreet C., Knight, Gwenan M., van Wamel, Willem J. B.]
通讯作者:
van Wamel, Willem J. B.
Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: killers and drivers of resistance evolution
模拟噬菌体和抗生素对细菌的协同效应:耐药性进化的杀手和驱动因素
DOI:
10.1101/2022.03.02.480504
发表时间:
2022
期刊:
影响因子:
--
作者:
[Leclerc Q]
通讯作者:
Leclerc Q
共 6 条
国内基金
海外基金
登录
查看更多内容
去铁胺修饰Fe3+-鞣花酸纳米酶敷料靶向杀灭MRSA促进糖尿病伤口愈合机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢颖
-
依托单位:
野菊花内生真菌中抗MRSA活性成分及其作用机制
-
批准号:JCZRLH202601040
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
小分子化合物T-2307及其类似物通过PG-PMF-ATP通路抗MRSA感染的分子机制及应用研究
-
批准号:2026JJ30179
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:伍勇
-
依托单位:
靶向新航向:STAT3抑制剂对MRSA的抗菌作用及其分子机制研究
-
批准号:2026JJ50552
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴苑
-
依托单位:
基于天然产物吴茱萸次碱的抗MRSA先导发现、结构优化及机制研究
-
批准号:2026JJ50341
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨瑞阁
-
依托单位:
黎药红葱中靶向sarA蛋白抗MRSA生物被膜活性萘醌类成分及其作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈德力
-
依托单位:
基于中性粒细胞活化探讨食源性酿酒酵母葡聚糖SG90抗MRSA感染的免疫机制研究
-
批准号:JCZRLH202600868
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
新型抗MRSA先导化合物作用靶标PflB的确证及抗菌机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:程琦
-
依托单位:
基于基因组溯源方法体系阐明MRSA跨种
属传播机制和风险
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:叶小华
-
依托单位:
两株黄连内生真菌抗MRSA活性成分的发现及作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:尹国平
-
依托单位: